M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection. [electronic resource]
Producer: 20181019Description: 41240 p. digitalISSN:- 2045-2322
- Allergens -- immunology
- Animals
- Bacterial Load -- immunology
- Humans
- Interleukin-1 Receptor-Like 1 Protein -- immunology
- Interleukin-33 -- genetics
- Lung -- immunology
- Macrophages -- drug effects
- Mice
- Mycobacterium tuberculosis -- immunology
- Signal Transduction -- drug effects
- Tuberculosis -- genetics
- Tuberculosis, Pulmonary -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.